Member Info for D-Geeman

Your first post was clear to me Stan. Don't think you needed to clarify but fine that you have done.

Thanks gmcc. Upon reading your history for the last couple of weeks I'm inclined to believe what you posted.

I thought you'd green binned me Mr R. You seem to have Boris Johnson's relationship with 'the truth'.

Yes, Eve was a shame. Wyn made quite a bit there and I lost. He arrived saying it might go bust and I'd argue with him, saying it was going to pull around and I'd do well. How did that turn out then? I still blame Putin.

Anyway, you know all about eve as I recall you posting there as you've done on HARL and elsewhere, following Wyn around, after trading tips I guess :-)

Nothing to be ashamed of. I wish I could trade. 600% on a short term trade on SYME is to be proud of and you obviously were in January (just a bit awkward today..)

I am wondering whether to buy a bit more AVCT at these prices. Buy on the dips. I don't really trade at all so any advice would be welcome.

Wyn's biggest fangirl appears to be ... Mr R.

Binned Wyn 4 times, and un-binned him 4 times. Must be a record. Can't live with him, can't live without him. Addicted obviously.

'I wish you the absolute best luck trying to paint me as a trader. hahahahahahahahahahahahahahahahahahahahahahahahahahahahahahahahahahahahahahahahahahahahahahaahahahahahahahahahahahahahahahahahshshshshshahhahahahahha not a ******* chance you stupid twat.'

And yet...

MrRipley
Posted in: AVCT
Posts: 3,471
Price: 119.00
No Opinion
RE: My Avacta Journey, (so far)03 Jan 2023 13:04

'.....I was in Syme Doctor. Jumped in purely on how much it was being pumped knowing it was going to be very short term. 600% I got out with. And never looked back. ARB did circa 1000% but over a few sessions.'

Agreed Tim, 'Bonkers'. Especially as my last buy was above 170p.

Wyn, I reckon it was directed at 'I’m a concerned holder underwater' – ic152, but nevertheless interesting that you think it could soon be a time to buy.

I'm not really concerned about a low ball offer being accepted by retail shareholders based on relatively low sp – based only on 'poor comms'.

If AS does have good news in his back pocket, releasing it in response to the low offer would escalate the sp pretty quickly.

He's held on to bad news without communicating it. He's held onto good news without communicating it. I wonder whether it's simply that he doesn't want to set a precedence in releasing news ie if he doesn't release good news then there's less imperative to release any bad news; ie. little or no running commentary.

It does mean that people have to make a judgment call (gamble) on whether he's withholding good news or bad news at any particular time.

'it's playing havoc with my OCD'

At last, an AVA6k side effect from the trial...

Thanks Yanis. So many shares down at the moment and I'm trying to work out which ones will best bounce-back. I should have bought here when you first mentioned it!
atb, D

Might it be true to say that the docs would want AVA6K to hit the tumour hard and fast as possible so as not to allow any 'less FAPpy' cells to hand around and then take-over? How intrinsic is FAP expression to the tumours that are being targeted. Is it absolutely part of their character?

(I see that Mr Ripley has stalked across to the HARL bb, as he once did with me elsewhere. Odd to green bin someone and then stalk them. Must be addicted.)

For 10 trading days (at least) let's hope!

Hi Yanis,
Just popping by to sense the mood here. I have some SIPP tax relief due into my acc. shortly and and looking at the options.
Trust all's well with you.

I checked half an hour ago and the sp was up 6% so I rather expected some trades to appear. Nothing has and now the sp is back down, so unmoved.

No trades have appeared.

Opposite of a tree-shake?

I sold my holding a few weeks ago. Thought I'd made a mistake when these RNS began, two new agreements. Seems they haven't moved the sp at all.

I still have my warrants for 5p till April 2024 (I think from memory) so if the price does suddenly shoot up I will exercise them. Some reassurance at least that I won't lose out completely on a change in fortune for Xeros.

https://www.koreabiomed.com/news/articleViewAmp.html?amp_gsa=1&_js_v=a9&idxno=13252&usqp=mq331AQIUAKwASCAAgM%3D#amp_ct=1679074725723&_tf=From%20%251%24s&aoh=16790745299848&referrer=https%3A%2F%2Fwww.google.com&share=https%3A%2F%2Fwww.koreabiomed.com%2Fnews%2FarticleView.html%3Fidxno%3D13252

Was that the one?

Same subject, just now another tweet:
'Thank you @BWHNeurology for sharing the great news about the publication in @PNASNews featuring our lead asset Foralumab. The worlds only fully human, anti-CD3 mAb, which we are delivering nasally to #MS patients. We will be starting a full Phase 2 trial soon in #SPMS. $TLSA'

An acquaintance of ours has liver cancer. He found out last summer around the time of the Jubilee. He's refused treatment as he saw what lung cancer did for his wife.

He went travelling and fishing in East Timor, Australia and Tasmania for UK's winter instead, which I rather admire. I'm guessing he's due back shortly but who knows.

Last year's RNS dates (so perhaps expect similar on Tuesday 28th March this year?) – though AACR is a week later this year, compared to 2022.

29th Mar 2022 7:00 am RNS AVA6000 data poster presentation at AACR
("Avacta to present pre-clinical data on AVA6000 at the American Association for Cancer Research Annual Meeting")

30th Mar 2022 7:00 am RNS Notice of Results and Investor Presentation

Fall today: AVCT are less likely to go to the Nasdaq after the UK budget..

Off topic but If anyone does have too much time on their hands, this is worth a read. I last read it in 2016 and it just popped up again while searching
https://www.thetimes.co.uk/article/aa-gill-final-piece-qt00nj9gm